Actual Medicinal Product (AMP) Doxepin 25mg capsules (Crescent Pharma Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light. Store in airtight containers.
- Provenance
-
This compatibility recommendation is derived from Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd).
- Generic
- Doxepin
- Formulation
- Doxepin 25mg capsules
-
Doxepin
-
Doxepin 25mg capsules
-
Doxepin 25mg capsules (Crescent Pharma Ltd)
-
-
Doxepin 10mg capsules